US Stock MarketDetailed Quotes

ACAD ACADIA Pharmaceuticals

Watchlist
  • 14.730
  • -0.100-0.67%
Close Apr 25 16:00 ET
  • 14.890
  • +0.160+1.09%
Pre 04:03 ET
2.46BMarket Cap10.83P/E (TTM)

ACADIA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
31.85%957.8M
12.36%259.6M
18.28%250.4M
46.44%241.96M
73.75%205.83M
40.45%726.44M
69.27%231.04M
61.96%211.7M
22.79%165.24M
2.59%118.46M
Operating revenue
31.85%957.8M
12.36%259.6M
18.28%250.4M
46.44%241.96M
73.75%205.83M
40.45%726.44M
69.27%231.04M
61.96%211.7M
22.79%165.24M
2.59%118.46M
Cost of revenue
96.55%81.84M
21.87%21.8M
28.96%18.86M
144.40%18.23M
1,276.78%22.95M
309.58%41.64M
641.44%17.89M
584.55%14.62M
179.68%7.46M
-43.49%1.67M
Gross profit
27.91%875.96M
11.56%237.8M
17.49%231.54M
41.80%223.73M
56.58%182.88M
35.05%684.8M
58.98%213.15M
53.27%197.08M
19.62%157.78M
3.80%116.8M
Operating expense
4.42%791.68M
29.52%230.81M
-21.56%199.9M
24.92%193.3M
-1.59%167.67M
3.77%758.18M
-1.07%178.21M
59.84%254.85M
-6.53%154.74M
-24.46%170.38M
Selling and administrative expenses
20.14%488.43M
16.70%130.08M
36.17%133.29M
21.98%117.06M
6.67%107.99M
10.15%406.56M
6.77%111.47M
25.33%97.89M
6.75%95.97M
4.71%101.24M
Research and development costs
-13.76%303.25M
50.93%100.73M
-57.57%66.61M
29.71%76.23M
-13.69%59.68M
-2.75%351.62M
-11.88%66.74M
92.98%156.96M
-22.31%58.77M
-46.34%69.14M
Operating profit
214.85%84.28M
-80.00%6.99M
154.77%31.64M
902.21%30.44M
128.39%15.21M
67.18%-73.38M
175.86%34.94M
-87.18%-57.78M
109.02%3.04M
52.59%-53.58M
Net non-operating interest income expense
47.72%25.46M
47.24%7.01M
59.66%6.59M
39.76%6.36M
44.89%5.51M
160.73%17.23M
31.10%4.76M
79.74%4.13M
684.48%4.55M
3,519.05%3.8M
Non-operating interest income
47.72%25.46M
47.24%7.01M
59.66%6.59M
39.76%6.36M
44.89%5.51M
160.73%17.23M
31.10%4.76M
79.74%4.13M
684.48%4.55M
3,519.05%3.8M
Other net income (expense)
2,803.46%148.34M
147.09M
-61.80%576K
131.03%386K
-94.10%286K
44.24%5.11M
0
-30.06%1.51M
-150.30%-1.24M
1,325.00%4.85M
Special income (charges)
--146.52M
----
----
----
----
--0
----
----
----
----
-Gain on sale of property,plant,equipment
--146.52M
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
-64.32%1.82M
--575K
-61.80%576K
131.03%386K
-94.10%286K
44.24%5.11M
--0
-30.06%1.51M
-150.30%-1.24M
1,325.00%4.85M
Income before tax
605.67%258.08M
305.73%161.09M
174.42%38.81M
486.19%37.18M
146.73%21M
76.09%-51.04M
197.10%39.7M
-97.40%-52.14M
118.90%6.34M
60.08%-44.94M
Income tax
208.53%31.62M
384.59%17.34M
-53.65%6.04M
-27.46%3.79M
331.86%4.45M
304.98%10.25M
-829.82%-6.09M
1,597.01%13.03M
1,080.36%5.23M
-495.46%-1.92M
Net income
469.50%226.45M
213.87%143.74M
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
Net income continuous Operations
469.50%226.45M
213.87%143.74M
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
Minority interest income
Net income attributable to the parent company
469.50%226.45M
213.87%143.74M
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
469.50%226.45M
213.87%143.74M
150.27%32.77M
2,897.22%33.39M
138.48%16.56M
71.62%-61.29M
209.76%45.8M
-139.77%-65.18M
103.28%1.11M
61.95%-43.02M
Basic earnings per share
470.27%1.37
207.14%0.86
150.00%0.2
1,900.00%0.2
137.04%0.1
72.39%-0.37
207.69%0.28
-135.29%-0.4
104.76%0.01
61.43%-0.27
Diluted earnings per share
467.57%1.36
207.14%0.86
150.00%0.2
1,900.00%0.2
137.04%0.1
72.39%-0.37
207.69%0.28
-135.29%-0.4
104.76%0.01
61.43%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 31.85%957.8M12.36%259.6M18.28%250.4M46.44%241.96M73.75%205.83M40.45%726.44M69.27%231.04M61.96%211.7M22.79%165.24M2.59%118.46M
Operating revenue 31.85%957.8M12.36%259.6M18.28%250.4M46.44%241.96M73.75%205.83M40.45%726.44M69.27%231.04M61.96%211.7M22.79%165.24M2.59%118.46M
Cost of revenue 96.55%81.84M21.87%21.8M28.96%18.86M144.40%18.23M1,276.78%22.95M309.58%41.64M641.44%17.89M584.55%14.62M179.68%7.46M-43.49%1.67M
Gross profit 27.91%875.96M11.56%237.8M17.49%231.54M41.80%223.73M56.58%182.88M35.05%684.8M58.98%213.15M53.27%197.08M19.62%157.78M3.80%116.8M
Operating expense 4.42%791.68M29.52%230.81M-21.56%199.9M24.92%193.3M-1.59%167.67M3.77%758.18M-1.07%178.21M59.84%254.85M-6.53%154.74M-24.46%170.38M
Selling and administrative expenses 20.14%488.43M16.70%130.08M36.17%133.29M21.98%117.06M6.67%107.99M10.15%406.56M6.77%111.47M25.33%97.89M6.75%95.97M4.71%101.24M
Research and development costs -13.76%303.25M50.93%100.73M-57.57%66.61M29.71%76.23M-13.69%59.68M-2.75%351.62M-11.88%66.74M92.98%156.96M-22.31%58.77M-46.34%69.14M
Operating profit 214.85%84.28M-80.00%6.99M154.77%31.64M902.21%30.44M128.39%15.21M67.18%-73.38M175.86%34.94M-87.18%-57.78M109.02%3.04M52.59%-53.58M
Net non-operating interest income expense 47.72%25.46M47.24%7.01M59.66%6.59M39.76%6.36M44.89%5.51M160.73%17.23M31.10%4.76M79.74%4.13M684.48%4.55M3,519.05%3.8M
Non-operating interest income 47.72%25.46M47.24%7.01M59.66%6.59M39.76%6.36M44.89%5.51M160.73%17.23M31.10%4.76M79.74%4.13M684.48%4.55M3,519.05%3.8M
Other net income (expense) 2,803.46%148.34M147.09M-61.80%576K131.03%386K-94.10%286K44.24%5.11M0-30.06%1.51M-150.30%-1.24M1,325.00%4.85M
Special income (charges) --146.52M------------------0----------------
-Gain on sale of property,plant,equipment --146.52M------------------0----------------
Other non- operating income (expenses) -64.32%1.82M--575K-61.80%576K131.03%386K-94.10%286K44.24%5.11M--0-30.06%1.51M-150.30%-1.24M1,325.00%4.85M
Income before tax 605.67%258.08M305.73%161.09M174.42%38.81M486.19%37.18M146.73%21M76.09%-51.04M197.10%39.7M-97.40%-52.14M118.90%6.34M60.08%-44.94M
Income tax 208.53%31.62M384.59%17.34M-53.65%6.04M-27.46%3.79M331.86%4.45M304.98%10.25M-829.82%-6.09M1,597.01%13.03M1,080.36%5.23M-495.46%-1.92M
Net income 469.50%226.45M213.87%143.74M150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M
Net income continuous Operations 469.50%226.45M213.87%143.74M150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M
Minority interest income
Net income attributable to the parent company 469.50%226.45M213.87%143.74M150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 469.50%226.45M213.87%143.74M150.27%32.77M2,897.22%33.39M138.48%16.56M71.62%-61.29M209.76%45.8M-139.77%-65.18M103.28%1.11M61.95%-43.02M
Basic earnings per share 470.27%1.37207.14%0.86150.00%0.21,900.00%0.2137.04%0.172.39%-0.37207.69%0.28-135.29%-0.4104.76%0.0161.43%-0.27
Diluted earnings per share 467.57%1.36207.14%0.86150.00%0.21,900.00%0.2137.04%0.172.39%-0.37207.69%0.28-135.29%-0.4104.76%0.0161.43%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Tesla
TSLA
284.950
Strategy
MSTR
368.710
Coinbase
COIN
209.640
4
Meta Platforms
META
547.270
5
MARA Holdings
MARA
14.300
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025